Healthcare
Wednesday, January 25, 2017
BRIEF-Myovant Sciences initiates phase 3 clinical program of Relugolix
* Myovant Sciences initiates phase 3 clinical program of
Relugolix in women with heavy menstrual bleeding associated with
uterine fibroids
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment